Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0289-2026

Artegraft Collagen Vascular Graft; REF: AG1015; Recall

Artegraft¿ Collagen Vascular Graft; REF: AG1015;

FDA recall Class II

Ongoing

FDA lists this Class II recall for Artegraft Collagen Vascular Graft; REF: AG1015;. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0289-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Sep 25, 2025
FDA report date
Oct 29, 2025
Quantity in commerce
1 unit
Distribution
See key details
FDA cause
Packaging change control

What is being recalled?

Artegraft Collagen Vascular Graft; REF: AG1015;

Affected model & UDI checker

Search the exact identifiers published for Z-0289-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
AG1015Artegraft Collagen Vascular Graft; REF: AG1015;Check source noticeNot specified
Not specifiedArtegraft Collagen Vascular Graft; REF: AG1015;Check source notice00316837000343
FDA code information

REF: AG1015; UDI-DI: 00316837000343; Lot/Serial Number: 23MM581-016;

View the original FDA recall notice

Why was this product recalled?

The device was incorrectly packed in the wrong size labeled outer packaging.

What actions did LeMaitre Vascular, Inc. take?

On September 25, 2025, an "URGENT: MEDICAL DEVICE RECALL" letter was sent to the customer. Actions to be taken: Check your inventory against the list of lots in this letter. Immediately quarantine any recalled devices. Complete and return the form provided even if you have no devices in inventory. If the product has been implanted, graft explantation/patient intervention is NOT required. Scan the reply form and send it to recalls@lemaitre.com. When a recalled device has been returned to LeMaitre Vascular, a replacement device will be provided. If you have transferred devices to another facility, please forward a copy of this recall letter to them. If you have any questions, contact Sr. Director, Quality Affairs, via email: mnelson@lemaitre.com or at 732-422-8333 Monday through Friday, 8:00AM to 4:30 PM, Eastern Time.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology